Long-term efficacy of first-line versus second-line pegylated interferon in the treatment of essential thrombocythaemia and polycythaemia vera - results of a single-centre retrospective audit

被引：0
|
作者：
James, Daniel [1 ]
Verigou, Eleni-Anna [1 ]
Wilson, Andrew [2 ]
O'Nions, Jenny [2 ]
Ahmed, Syeda [2 ]
Alimam, Samah [3 ]
Sekhar, Mallika [2 ]
Lambert, Jonathan [2 ]
机构：
[1] UCL, Sch Med, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2021-PO
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [41] Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): Focus on Long-Term MRD Results
    Jain, Nitin
    Keating, Michael J.
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Burger, Jan A.
    Borthakur, Gautam
    Takahashi, Koichi
    Estrov, Zeev E.
    Sasaki, Koji
    Kadia, Tapan M.
    Konopleva, Marina
    Alvarado, Yesid
    Yilmaz, Musa
    DiNardo, Courtney D.
    Bose, Prithviraj
    Ohanian, Maro
    Pemmaraju, Naveen
    Jabbour, Elias J.
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Wang, Wei
    Jorgensen, Jeffrey L.
    Wang, Sa A.
    Garg, Naveen
    Wang, Xuemei
    Wei, Chongjuan
    Cruz, Nichole
    Ayala, Ana
    Plunkett, William
    Kantarjian, Hagop
    Gandhi, Varsha
    Wierda, William G.
    BLOOD, 2021, 138 : 3720 - +
  • [42] Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up
    Waki, Koji
    Aikata, Hiroshi
    Katamura, Yoshio
    Kawaoka, Tomokazu
    Takaki, Shintaro
    Hiramatsu, Akira
    Takahashi, Shoichi
    Toyota, Naoyuki
    Ito, Katsuhide
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (03) : 597 - 604
  • [43] Trastuzumab plus lapatinib for second-line treatment of human epidermal growth factor receptor 2-positive advanced biliary tract adenocarcinoma: A retrospective single-centre study
    Mondal, D.
    Roy, R.
    Meyur, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S131 - S131
  • [44] Long-term efficacy and cost-effectiveness of infliximab as first-line treatment in rheumatoid arthritis: systematic review and meta-analysis
    Zrubka, Zsombor
    Gulacsi, Laszlo
    Brodszky, Valentin
    Rencz, Fanni
    Alten, Rieke
    Szekanecz, Zoltan
    Pentek, Marta
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (05) : 537 - 549
  • [45] Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results from the Long-Term Extension (LTE) of the Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT) Study
    Larsen, C.
    Vincenti, F.
    Grinyo, J.
    Rice, K.
    Steinberg, S.
    Gaite, L.
    Moal, M.
    Pupim, L.
    Rostaing, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 312 - 312
  • [46] Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma
    Rini, Brian, I
    Signoretti, Sabina
    Choueiri, Toni K.
    McDermott, David F.
    Motzer, Robert J.
    George, Saby
    Powles, Thomas
    Donskov, Frede
    Tykodi, Scott S.
    Pal, Sumanta K.
    Gupta, Saurabh
    Lee, Chung-Wei
    Jiang, Ruiyun
    Tannir, Nizar M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
  • [47] Second-line treatment in steroid refractory acute graft-versus-host disease during a 10-year period: a single-centre experience comparing 3 strategies
    Xhaard, A.
    Porcher, R.
    Rocha, V.
    de Latour, R. Peffault
    Bueno, B.
    Lenglet, J.
    Petropoulou, A.
    Rodriguez-Otero, P.
    Ribaud, P.
    Socie, G.
    Robin, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S106 - S106
  • [48] A Randomized Open Label Study Comparing First-Line Treatment With Bosentan Or Sildenafil In Pulmonary Arterial Hypertension (pah): Long-Term Results
    Mazzanti, G.
    Palazzini, M.
    Albini, A.
    Terzi, F.
    Bachetti, C.
    Conficoni, E.
    Monti, E.
    Gotti, E.
    Rizzo, N.
    Dardi, F.
    Rinaldi, A.
    Manes, A.
    Galie, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [49] Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1 L) maintenance with or without second-line (2 L) treatment: Exploratory analyses from JAVELIN Bladder 100
    Bellmunt, Joaquim
    Powles, Thomas
    Duran, Miguel A. Climent
    Sridhar, Srikala S.
    Gurney, Howard
    Pook, David W.
    Costa, Nuno
    Di Pietro, Alessandra
    Huang, Bo
    Gupta, Shilpa
    Grivas, Petros
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 137 - 138
  • [50] Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis
    Sheng, Xinan
    Chi, Zhihong
    Cui, Chuanliang
    Si, Lu
    Li, Siming
    Tang, Bixia
    Mao, Lili
    Lian, Bin
    Wang, Xuan
    Yan, Xieqiao
    Guo, Jun
    ONCOTARGET, 2016, 7 (19) : 27044 - 27054
12345